Healthcare & Medical Devices Global On demand · 24-48h

Global Expandable Embolization Coils Market Strategic Research Report

Global Expandable Embolization Coils Market Strategic Resear…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Expandable Embolization Coils Market
$1.59B2025
9%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Pushable, Detachable

By Application: Neurovascular Embolization, Peripheral Vascular Embolization

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Terumo Corporation, Shape Memory Medical Inc., Boston Scientific Corporation, Medtronic, Penumbra, Inc., Stryker Corporation, Johnson & Johnson (Cerenovus), Balt Group, Cook Medical, Wallaby Medical, Achieva Medical (Peijia Medical), MicroPort NeuroTech, Beijing Taijie Weiye Medical Technology, Zylox-Tonbridge Medical, Shandong Weixin Medical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 120 pages
Market size 2025
$1.59B
Billion USD
Forecast CAGR
9%
2025-2032
Forecast 2032
$2.9B
Projected
Gebieden
5
Asia Pacific · Latin America · MEA · Europe · North America

Overzicht

Scope of the Report

The global Expandable Embolization Coils market size is predicted to grow from US$ 1,590 million in 2025 to US$ 2,884 million in 2032; it is expected to grow at a CAGR of 9.0% from 2026 to 2032.

Expandable embolization coils are specialized medical devices used in interventional radiology and neurointervention to occlude blood flow in targeted vessels. These devices are typically delivered through a microcatheter and, upon deployment, expand to fill the target vessel or aneurysm sac, promoting thrombus formation and permanent vessel occlusion. The expandable design allows for denser packing and improved occlusion rates compared to standard coils. The global average selling price for expandable embolization coils is approximately US$200 per unit. The average sales volume in the base year is estimated at 8,125.0k units. The industry average gross margin is approximately 65%, with typical ranges between 55% and 75%, reflecting the high-precision manufacturing, proprietary technologies, and significant clinical value of these devices. The upstream segment includes manufacturers of platinum alloys, nitinol, shape memory polymers, hydrogel polymers, and precision delivery system components. The midstream segment comprises device manufacturers that design, assemble, and sterilize finished coil systems. The downstream segment encompasses hospitals, interventional radiology departments, neurovascular centers, and catheterization laboratories where these coils are used for intracranial aneurysm embolization, peripheral vascular embolization, and other vascular occlusion procedures.

The expandable embolization coil market is experiencing robust growth driven by the increasing prevalence of intracranial aneurysms and peripheral vascular diseases, rising adoption of minimally invasive endovascular procedures, and continuous technological innovation in coil design and materials. The global neurointerventional market, of which embolization coils are a core segment, is estimated at approximately US$7 billion annually, with China accounting for 15%–20% and the international market presenting significant growth opportunities. The expandable coil segment is benefiting from technological advancements including hydrogel expansion technology, which can achieve the same packing density with fewer coils, and shape memory polymer scaffolds that support rapid clot formation and organized thrombus development. The evolution from bare platinum coils to hydrogel-coated and polymer-augmented designs represents a fundamental shift in treatment paradigms, as these innovations enable higher volumetric filling and improved long-term occlusion stability. The industry is witnessing a trend toward combination therapies, with coils used alongside flow diverters and liquid embolic agents for complex vascular lesions. Regulatory frameworks continue to evolve to accommodate novel coil designs, with an increasing emphasis on clinical evidence demonstrating safety and efficacy across diverse patient populations. The Asia-Pacific region is emerging as the fastest-growing regional market, driven by improving healthcare infrastructure, rising procedure volumes (China's coil embolization procedures growing at a CAGR of 17.3% from 2018 to 2025), and the expansion of domestic manufacturers. However, the market remains concentrated, with international players holding approximately 80% of the Chinese market share, though domestic companies are actively gaining ground through innovation and cost advantages.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Expandable Embolization Coils market?

What factors are driving Expandable Embolization Coils market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Expandable Embolization Coils market opportunities vary by end market size?

How does Expandable Embolization Coils break out by Type, by Application?

This report presents a comprehensive overview of the global Expandable Embolization Coils market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Pushable
  • Detachable

Segment by Coil Diameter

  • Microcoils (≤ 0.018 inch)
  • Standard Coils (0.018 – 0.035 inch)
  • Large Coils (> 0.035 inch)

Segment by Application

  • Hospital
  • Clinic
  • Other

Segment by Application

  • Neurovascular Embolization
  • Peripheral Vascular Embolization

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Expandable Embolization Coils market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Neurovascular Embolization, Peripheral Vascular Embolization evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Expandable Embolization Coils Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 9%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.59B
2025
Forecast
$2.9B
2032
CAGR
9%
2025–2032
Gebieden
5
global
Key companies
Terumo CorporationShape Memory Medical Inc.Boston Scientific CorporationMedtronicPenumbra, Inc.Stryker CorporationJohnson & Johnson (Cerenovus)Balt Group
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
PushableDetachable
By Application
Neurovascular EmbolizationPeripheral Vascular Embolization

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Pushable
  • 3.1.3 Detachable
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Neurovascular Embolization
  • 4.1.3 Peripheral Vascular Embolization
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Terumo Corporation
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Shape Memory Medical Inc.
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Boston Scientific Corporation
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Medtronic
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Penumbra, Inc.
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Stryker Corporation
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Johnson & Johnson (Cerenovus)
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Balt Group
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Cook Medical
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Wallaby Medical
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Achieva Medical (Peijia Medical)
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 MicroPort NeuroTech
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Beijing Taijie Weiye Medical Technology
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Zylox-Tonbridge Medical
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Shandong Weixin Medical
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Expandable Embolization Coils market?
The global Expandable Embolization Coils market is estimated at US$ 1.59 billion in 2025 (base year) and is projected to reach US$ 2.88 billion by 2032.
How fast is the Expandable Embolization Coils market expected to grow?
The market is expected to grow at a CAGR of 9.0% from 2026 to 2032, expanding from US$ 1.59 billion in 2025 to US$ 2.88 billion in 2032, roughly 1.8 times its base-year value.
What does the Expandable Embolization Coils market cover?
Expandable embolization coils are specialized medical devices used in interventional radiology and neurointervention to occlude blood flow in targeted vessels. These devices are typically delivered through a microcatheter and, upon deployment, expand to fill the target vessel or aneurysm sac, promoting thrombus formation and permanent vessel occlusion. The expandable design allows for denser packing and improved occlusion rates compared to standard coils.
What are the main segments of the Expandable Embolization Coils market by type?
By type, the market is segmented into Pushable and Detachable.
Which applications drive demand in the Expandable Embolization Coils market?
Key applications covered include Neurovascular Embolization and Peripheral Vascular Embolization.
Who are the key players in the Expandable Embolization Coils market?
Key players profiled include Terumo Corporation, Shape Memory Medical Inc., Boston Scientific Corporation, Medtronic, Penumbra, Stryker Corporation, Johnson & Johnson (Cerenovus) and Balt Group, among 15 companies covered in total.
Which regions and countries are covered for Expandable Embolization Coils?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Expandable Embolization Coils market?
The expandable embolization coil market is experiencing robust growth driven by the increasing prevalence of intracranial aneurysms and peripheral vascular diseases, rising adoption of minimally invasive endovascular procedures, and continuous technological innovation in coil design and materials.
Who should buy the Expandable Embolization Coils market report?
The report is intended for manufacturers and solution providers, distributors and end users in Neurovascular Embolization and Peripheral Vascular Embolization, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Expandable Embolization Coils market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.